ARTICLE | Clinical News
Abasol abafungin regulatory update
August 1, 2005 7:00 AM UTC
York Pharma plc (LSE:YRK), Hertfordshire, U.K. Product: Abasol abafungin Business: Infectious YRK submitted an MAA in the U.K. under the mutual recognition procedure for its Abasol abafungin to treat...